Cargando…
Optimal Decision Rules for Biomarker-Based Subgroup Selection for a Targeted Therapy in Oncology
Throughout recent years, there has been a rapidly increasing interest regarding the evaluation of so-called targeted therapies. These therapies are assumed to show a greater benefit in a pre-specified subgroup of patients—commonly identified by a predictive biomarker—as compared to the total patient...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463650/ https://www.ncbi.nlm.nih.gov/pubmed/25961947 http://dx.doi.org/10.3390/ijms160510354 |